AF
CRBU icon

Allworth Financial’s Caribou Biosciences CRBU Stock Holding History

Allworth Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.9K Hold
9,430
– – ﹤0.01% 3072
2025
Q4 		$15K Buy
+9,430
New +$19.8K ﹤0.01% 2991
2025
Q3 		– Sell
-156
Closed -$197 – 4936
2025
Q2 		$197 Buy
+156
New +$153 ﹤0.01% 4316
2023
Q1 		– Sell
-530
Closed -$3.33K – 3212
2022
Q4 		$3.33K Hold
530
– – ﹤0.01% 2052
2022
Q3 		$6K Hold
530
– – ﹤0.01% 1814
2022
Q2 		$3K Hold
530
– – ﹤0.01% 1874
2022
Q1 		$5K Buy
+530
New +$5.58K ﹤0.01% 1621

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allworth Financial's CRBU Position: Q1 2026 in Review

Allworth Financial held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 9,430 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

Allworth Financial first reported a position in CRBU in Q1 2022 and has held it in 7 quarters since. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Allworth Financial held 9,430 shares of Caribou Biosciences worth $17.9K as of Q1 2026.
  • Allworth Financial left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3072 holding.
  • Allworth Financial first reported a position in Caribou Biosciences in Q1 2022 and has held it in 7 quarters since.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.